Inactive Instrument
Mymetics Corporation Share Price Other OTC
Stocks
MYMX
US62856A1025
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4L 4L 4L 3L 6L 4.14Cr 6L 42.61L 16.5L 2.04Cr 16.48L 16.12L 7.09Cr | P/E 2021 |
-1.86x | P/E 2022 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 7.21Cr 6.34Cr 5.84Cr 5.46Cr 10Cr 680.55Cr 10Cr 70Cr 27Cr 335.48Cr 27Cr 26Cr 1.17TCr | EV / Sales 2021 |
177x | EV / Sales 2022 | 78x |
| Free-Float |
99.88% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 19/11/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.24% | +8.79% | - | - | 45 | |
| +4.43% | +2.49% | +61.83% | +115.25% | 5.29TCr | |
| +1.58% | +14.12% | +72.87% | +85.18% | 5.1TCr | |
| -0.23% | -0.98% | -14.12% | -16.00% | 2.28TCr | |
| +0.98% | +9.05% | -0.36% | +423.40% | 2.24TCr | |
| -1.63% | +5.86% | +30.16% | -15.37% | 1.7TCr | |
| +0.88% | +5.78% | +30.82% | -34.26% | 1.59TCr | |
| +3.02% | +12.74% | +143.33% | +308.04% | 1.36TCr | |
| +0.68% | +2.54% | +22.28% | +168.03% | 1.33TCr | |
| -0.05% | +5.10% | +26.89% | - | 1.26TCr | |
| Average | -0.06% | +6.25% | +41.52% | +129.28% | 2.46TCr | |
| Weighted average by Cap. | +1.65% | +6.70% | +46.23% | +120.52% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 4L 4L 3L 3L 6L 4.06Cr 6L 41.75L 16.17L 2Cr 16.15L 15.79L 6.95Cr | 10.28L 9L 8L 8L 14.59L 9.7Cr 14.86L 99.82L 38.66L 4.78Cr 38.6L 37.76L 17Cr |
| Net income | -47.3L -41.55L -38.28L -35.79L -67.13L -45Cr -68.36L -4.59Cr -1.78Cr -22Cr -1.78Cr -1.74Cr -76Cr | -48.05L -42.21L -38.89L -36.36L -68.19L -45Cr -69.45L -4.67Cr -1.81Cr -22Cr -1.8Cr -1.76Cr -78Cr |
| Net Debt | 6.71Cr 5.89Cr 5.43Cr 5.08Cr 9.52Cr 633.16Cr 9.7Cr 65Cr 25Cr 312.11Cr 25Cr 25Cr 1.08TCr | 7.17Cr 6.3Cr 5.8Cr 5.42Cr 10Cr 676.41Cr 10Cr 70Cr 27Cr 333.43Cr 27Cr 26Cr 1.16TCr |
Employees
-
